Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar

References

• Ahmad, A., Ahmad, A., Sudhakar, R., Varshney, H., Subbarao, N., Ansari, S., … Khan, A. U. (2016). Designing, synthesis, and antimicrobial action of oxazoline and thiazoline derivatives of fatty acid esters. Journal of Biomolecular Structure and Dynamics, 1–20.10.1080/07391102.2016.1255260
   Web of Science ®Google Scholar
• Ammazzalorso, A., Carrieri, A., Verginelli, F., Bruno, I., Carbonara, G., D’Angelo, A., … Amoroso, R. (2016). Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors alpha antagonists. European Journal of Medicinal Chemistry, 114, 191–200.10.1016/j.ejmech.2016.02.064
   PubMed Web of Science ®Google Scholar
• Aravind Sosale, S., Saboo, B., & Sosale, B. (2015). Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: Current evidence. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 8, 189.10.2147/DMSO
   Google Scholar
• Baby, S. T., Sharma, S., Enaganti, S., & Cherian, P. R. (2016). Molecular docking and pharmacophore studies of heterocyclic compounds as heat shock protein 90 (Hsp90) inhibitors. Bioinformation, 12, 149–155.10.6026/bioinformation
   PubMed Web of Science ®Google Scholar
• Bugge, A., & Holst, D. (2017). PPAR agonists, – Could tissue targeting pave the way? Biochimie, 136, 100–104.10.1016/j.biochi.2016.10.017
   PubMed Web of Science ®Google Scholar
• Cronet, P. P. J., Folmer, R., Blomberg, N., Sjoblom, K., Karlsson, U., Lindstedt, E. L., Bamberg, K. (2001). Structure of the PPAR alpha and -gamma ligand binding domain in complex with AZ 242; Ligand selectivity and agonist activation in the PPAR family. Structure, 9(8), 699–706.10.1016/S0969-2126(01)00634-7
   PubMed Web of Science ®Google Scholar
• Darwish, K. M., Salama, I., Mostafa, S., Gomaa, M. S., & Helal, M. A. (2016). Design, synthesis, and biological evaluation of novel thiazolidinediones as PPAR gamma/FFAR1 dual agonists. European Journal of Medicinal Chemistry, 109, 157–172.10.1016/j.ejmech.2015.12.049
   PubMed Web of Science ®Google Scholar
• Fresno, N., Macías-González, M., Torres-Zaguirre, A., Romero-Cuevas, M., Sanz-Camacho, P., Elguero, J., … Pérez-Fernández, R. (2015). Novel oxazolidinone-based peroxisome proliferator activated receptor agonists: Molecular modeling, synthesis, and biological evaluation. Journal of Medicinal Chemistry, 58, 6639–6652.10.1021/acs.jmedchem.5b00849
   PubMed Web of Science ®Google Scholar
• Gao, Q., Hanh, J., Váradi, L., Cairns, R., Sjöström, H., Liao, V. W., … Hibbs, D. E. (2015). Identification of dual PPARalpha/gamma agonists and their effects on lipid metabolism. Bioorganic & Medicinal Chemistry, 23, 7676–7684.10.1016/j.bmc.2015.11.013
   PubMed Web of Science ®Google Scholar
• Gawande, N. D., Subashini, S., Murugan, M., & Subbarayalu, M. (2014). Molecular screening of insecticides with sigma glutathione S-transferases (GST) in cotton aphid Aphis gossypii using docking. Bioinformation, 10, 679–683.10.6026/bioinformation
   PubMedGoogle Scholar
• Gholami, S., Bordbar, A. K., & Lohrasebi, A. (2017). Identifying binding modes of two synthetic derivatives of adrenalin to the alpha 2C-adrenoceptor by using molecular modeling; insights into the alpha 2C-adrenoceptor activation. Biophysical Chemistry, 223, 17–24.10.1016/j.bpc.2017.01.005
   PubMed Web of Science ®Google Scholar
• Hayes, J. M., Skamnaki, V. T., Archontis, G., Lamprakis, C., Sarrou, J., Bischler, N., … Oikonomakos, N. G. (2011). Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: The role of water molecules examined. Proteins, 79, 703–719.10.1002/prot.22890
   PubMed Web of Science ®Google Scholar
• Hossain, M. U., Khan, M. A., Rakib-Uz-Zaman, S. M., Ali, M. T., Islam, M. S., Keya, C. A., & Salimullah, M., (2016) Treating diabetes mellitus: Pharmacophore based designing of potential drugs from gymnema sylvestre against insulin receptor protein. BioMed Research International, 2016, 14.
   Web of Science ®Google Scholar
• Huang, Y. D., Chen, W., Wallace, J. A., & Shen, J. (2016). All-atom continuous constant ph molecular dynamics with particle mesh Ewald and Titratable water. Journal of Chemical Theory and Computation, 12, 5411–5421.10.1021/acs.jctc.6b00552
   PubMed Web of Science ®Google Scholar
• Jain, M. R., Giri, S. R., Trivedi, C., Bhoi, B., Rath, A., Vanage, G., … Patel, P. R. (2015). Saroglitazar, a novel PPARα/γagonist with predominant PPARαactivity, shows lipid-lowering and insulin-sensitizing effects in preclinical models. Pharmacology Research & Perspectives, 3, e00136.10.1002/prp2.136
   PubMed Web of Science ®Google Scholar
• Jakubik, J., El-Fakahany, E. E., &Dolezal, V., (2015) Towards predictive docking at aminergic G-protein coupled receptors. The Journal of Molecular Modeling, 21.
   PubMed Web of Science ®Google Scholar
• Jani, R. H., Kansagra, K., Jain, M. R., & Patel, H. (2013). Pharmacokinetics, safety, and tolerability of saroglitazar (ZYH1), a predominantly PPAR alpha agonist with moderate PPAR gamma agonist activity in healthy human subjects. Clinical Drug Investigation, 33, 809–816.10.1007/s40261-013-0128-3
   PubMed Web of Science ®Google Scholar
• Joshi, S. R. (2015). Saroglitazar for the treatment of dyslipidemia in diabetic patients. Expert Opinion on Pharmacotherapy, 16, 597–606.10.1517/14656566.2015.1009894
   PubMed Web of Science ®Google Scholar
• Julin, J., Napari, I., Vehkamaki, H. (2007) Comparative study on methodology in molecular dynamics simulation of nucleation. The Journal of Chemical Physics, 126.
   PubMed Web of Science ®Google Scholar
• Kaczor, A. A., Targowska-Duda, K. M., Patel, J. Z., Laitinen, T., Parkkari, T., Adams, Y., … Poso, A. (2015). Comparative molecular field analysis and molecular dynamics studies of alpha/beta hydrolase domain containing 6 (ABHD6) inhibitors. Journal of Molecular Modeling, 21, 849.10.1007/s00894-015-2789-8
   Web of Science ®Google Scholar
• Kalathiya, U., Padariya, M., & Baginski, M. (2016). Identification of 1H-indene-(1,3,5,6)-tetrol derivatives as potent pancreatic lipase inhibitors using molecular docking and molecular dynamics approach. Biotechnology and Applied Biochemistry, 63, 765–778.10.1002/bab.2016.63.issue-6
   PubMed Web of Science ®Google Scholar
• Kallubai, M., Amineni, U., Mallavarapu, M., & Kadiyala, V. (2015). In silico approach to support that p-Nitrophenol Monooxygenase from Arthrobacter sp strain JS443 catalyzes the initial two sequential monooxygenations. Interdisciplinary Sciences, 7, 157–167.10.1007/s12539-015-0018-x
   PubMed Web of Science ®Google Scholar
• Katari, S. K., Natarajan, P., Swargam, S., Kanipakam, H., Pasala, C., & Umamaheswari, A. (2016). Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations. Journal of Receptors and Signal Transduction, 36, 558–571.10.3109/10799893.2016.1141955
   PubMed Web of Science ®Google Scholar
• Kirubakaran, P., Kothapalli, R., Singh, Kh. D., Nagamani, S., Arjunan, S., Muthusamy, K. (2011). In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme. Bioinformation, 6, 100–106.10.6026/bioinformation
   PubMedGoogle Scholar
• Li, Q., Peng, H., Fan, H., Zou, X., Liu, Q., Zhang, Y., & Hou, Z. (2015). The LIM protein Ajuba promotes adipogenesis by enhancing PPARγ and p300/CBP interaction. Cell Death and Differentiation, 23(1), 158–168.
   PubMed Web of Science ®Google Scholar
• Mazumder, M., Ponnan, P., Das, U., Gourinath, S., Khan, H. A., Yang, J., & Sakharkar, M. K. (2017). Investigations on binding pattern of kinase inhibitors with PPARγ: Molecular docking, molecular dynamic simulations, and free energy calculation studies. PPAR Research, 2017, 1–11.10.1155/2017/6397836
   Web of Science ®Google Scholar
• Mishra, G. P., & Sharma, R. (2016). Identification of potential PPAR gamma agonists as hypoglycemic agents: Molecular docking approach. Interdisciplinary Sciences, 8, 220–228.10.1007/s12539-015-0126-7
   PubMed Web of Science ®Google Scholar
• Mondal, S., Mandal, S. M., Mondal, T. K., & Sinha, C. (2015). Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 150, 268–279.10.1016/j.saa.2015.05.049
   PubMed Web of Science ®Google Scholar
• Muralikumar, S., Vetrivel, U., Narayanasamy, A., & Das, N. (2017). Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties. Lipids in Health and Disease, 16(1), 17.
   PubMed Web of Science ®Google Scholar
• Narayanaswamy, R., Isha, A., Wai, L. K., & Ismail, I. S. (2016). Molecular docking analysis of selected clinacanthus nutans constituents as xanthine oxidase, nitric oxide synthase, human neutrophil elastase, matrix metalloproteinase 2, matrix metalloproteinase 9 and squalene synthase inhibitors. Pharmacognosy Magazine, 12, S21–26.
   PubMed Web of Science ®Google Scholar
• Natarajan, A., Sugumar, S., Bitragunta, S., Balasubramanyan, N., (2015) Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes. BMC Complementary and Alternative Medicine, 15, 73.
   PubMed Web of Science ®Google Scholar
• Ndagi, U., Mhlongo, N. N., & Soliman, M. E. (2017). The impact of Thr91 mutation on c-Src resistance to UM-164: Molecular dynamics study revealed a new opportunity for drug design. Molecular BioSystems, 13(6), 1157–1171.
   PubMed Web of Science ®Google Scholar
• Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., … Milburn, M. V. (1998). Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature, 395, 137–143.
   PubMed Web of Science ®Google Scholar
• Norinder, U., & Bergström, C. A. (2006). Prediction of ADMET properties. ChemMedChem, 1, 920–937.10.1002/(ISSN)1860-7187
   PubMed Web of Science ®Google Scholar
• Pradhan, D., Priyadarshini, V., Munikumar, M., Swargam, S., Umamaheswari, A., & Bitla, A. (2013). Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC ofLeptospiraspp.: Homology modeling, docking, and molecular dynamics study. Journal of Biomolecular Structure and Dynamics, 32, 171–185.
   PubMed Web of Science ®Google Scholar
• Puratchikody, A., Sriram, D., Umamaheswari, A., & Irfan, N., (2016) 3-D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment. Chemistry Central Journal, 10, 24.
   PubMed Web of Science ®Google Scholar
• Rajamanikandan, S., & Srinivasan, P. (2016). Pharmacophore modeling and structure-based virtual screening to identify potent inhibitors targeting LuxP of Vibrio harveyi. Journal of Receptors and Signal Transduction, 36, 617–632.10.3109/10799893.2016.1155063
   PubMed Web of Science ®Google Scholar
• Shan, Y. B., Kim, E. T., Eastwood, M. P., Dror, R. O., Seeliger, M. A., & Shaw, D. E. (2011). How does a drug molecule find its target binding site? Journal of the American Chemical Society, 133, 9181–9183.10.1021/ja202726y
   PubMed Web of Science ®Google Scholar
• Singh, J., Kumar, M., Mansuri, R., Sahoo, G. C., & Deep, A. (2016). Inhibitor designing, virtual screening, and docking studies for methyltransferase: A potential target against dengue virus. Journal of pharmacy & bioallied sciences, 8, 188–194.
   PubMed Web of Science ®Google Scholar
• Singh, K. D., & Muthusamy, K. (2013). Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ETA receptor antagonists. Acta Pharmacologica Sinica, 34, 1592–1606.10.1038/aps.2013.129
   PubMed Web of Science ®Google Scholar
• Strahan, G. D., Keniry, M. A., & Shafer, R. H. (1998). NMR structure refinement and dynamics of the K+-[d(G(3)T(4)G(3))](2) quadruplex via particle mesh Ewald molecular dynamics simulations. Biophysical Journal, 75, 968–981.10.1016/S0006-3495(98)77585-X
   PubMed Web of Science ®Google Scholar
• Wang, X. J., Zhang, J., Wang, S. Q., Xu, W. R., Cheng, X. C., & Wang, R. L. (2014). Identification of novel multitargeted PPARalpha/gamma/delta pan agonists by core hopping of rosiglitazone. Drug design, development and therapy, 8, 2255–2262.
   PubMed Web of Science ®Google Scholar
• Yadava, U., Gupta, H., & Roychoudhury, M. (2015). Stabilization of microtubules by taxane diterpenoids: Insight from docking and MD simulations. Journal of Biological Physics, 41, 117–133.10.1007/s10867-014-9369-5
   PubMed Web of Science ®Google Scholar
• Yokoyama, M., Fujisaki, S., Shirakura, M., Watanabe, S., Odagiri, T., Ito, K., Sato, H., (2017) Molecular dynamics simulation of the influenza A(H3N2) hemagglutinin trimer reveals the structural basis for adaptive evolution of the recent epidemic clade 3C. 2a. Frontiers in Microbiology, 8, 584.
   PubMed Web of Science ®Google Scholar
• Zhang, D. W., & Lazim, R., (2017) Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Scientific Reports-Uk, 7, 44651.
   PubMed Web of Science ®Google Scholar
• Zhang, L. Q. (2017). Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study. Proteins, 85, 665–681.10.1002/prot.25247
   PubMed Web of Science ®Google Scholar
• Zoete, V., Grosdidier, A., & Michielin, O. (2006). Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators. Biochimica et Biophysica Acta, 1771, 915–925.
   Web of Science ®Google Scholar